False
Advertisement
January 2017
Welcome to the January issue of The Ophthalmologist. Upfront’s topics include IOP-sensing implants, subliminal imaging and the latest trial results for AMD therapies. In My View sees Hiroshi Ishikawa make the case for using anterior segment imaging in angle-closure glaucoma, and Brian Joondeph considers what a Trump presidency might mean for ophthalmologists. In our Feature, we hear from Michael Chiang about his work on EHRs and how the data they collect might be put to good use. In Practice sees Anat Loewenstein overview intraocular steroids in retinal diseases and Paul Beer presents his accommodating-disaccommodating (AD)-IOL concept in Next Gen. In Profession, Rod Solar discusses why more ophthalmologists should be making and posting video content, and shares his top tips. Finally, we Sit Down With George Waring IV, Assistant Professor of Ophthalmology and Director of Refractive Surgery, Medical University of South Carolina Storm Eye Institute, USA.
Beyond Bifocals
January 24, 2017
The Ophthalmologist, in conversation with Thomas Kohnen, recorded during the Alcon Multifocal IOL User Meeting in Prague, June 2016.
1 min read
The Ophthalmologist Power List 2017
January 23, 2017
Who are the “rising stars” in ophthalmology?
1 min read
A Long Term Look at CLASS
January 18, 2017
The 5-year trial results are in. How safe and effective is the CLASS procedure?
1 min read
A User's Guide to SLT
January 18, 2017
What benefits can SLT offer, and which patients are eligible?
1 min read
The Laser Quest for a Happy Medium
January 18, 2017
In glaucoma, medical management is plagued with noncompliance, and filtration surgery can be complex and risky. Could laser-based treatments offer a happy medium?
1 min read
Buy One, Get One (Almost) Free?
January 18, 2017
Why I believe it’s time to finally embrace immediate sequential bilateral cataract surgery
1 min read
Video: In Conversation With.....Ingeborg Stalmans
January 16, 2017
Prof. Stalmans shares her experience with Ultrasound Ciliary Plasty (UCP) for glaucoma treatment
1 min read
The Right Angle
January 12, 2017
Why anterior segment imaging is my gold standard method for diagnosing and monitoring angle-closure glaucoma
1 min read
No Synergy
January 12, 2017
In theory, pegpleranib + ranibizumab is better than ranibizumab alone. But Phase III results suggest otherwise…
1 min read
Hidden Depths
January 11, 2017
How much information do we retain about what we don’t see?
1 min read
The Clear Lens Warden
January 11, 2017
A gene associated with early-onset Parkinson’s disease appears to act against cataract formation
1 min read
“Miami, We Have a Problem”
January 11, 2017
A Florida-based team provides the first quantitative evidence for the role of CSF in spaceflight-induced ocular changes
1 min read
Same Difference
January 11, 2017
Real-world observational study comparing ranibizumab and aflibercept shows similar outcomes
1 min read
Diagnosis: Color
January 11, 2017
Could a color-changing implant monitor IOP in patients at risk of developing glaucoma?
1 min read
Hindsight for Foresight
January 11, 2017
Looking back at 2016’s predictions of the future
1 min read
Simulating Eyecare
January 11, 2017
Like them or loathe them, electronic health records are here to stay. Can we find a way to work with them and improve patient care?
1 min read
Consider the Alternative
January 11, 2017
When it comes to treating retinal disease, VEGF isn’t the only game in town
1 min read
A New Approach to Motion That Might Cause Commotion
January 11, 2017
Might we have hit on the right method to achieve true accommodation?
1 min read
(Pro)motion Pictures
January 11, 2017
Producing your own videos isn’t costly and could boost your profile online
1 min read
Family Man
January 11, 2017
Sitting Down With... George O. Waring IV, Associate Professor of Ophthalmology and Director of Refractive Surgery, Medical University of South Carolina (MUSC) Storm Eye Institute, Medical Director, MUSC Magill Vision Center, and Adjunct Assistant Professor of Bioengineering, Clemson University, South Carolina, USA.
1 min read
This Month in Business
November 14, 2014
Abbott and Zeiss join forces, Valeant and Allergan continue to battle
1 min read
Browse by Subspecialties
False
Advertisement